Publication Date:
2013-10-31
Description:
Phase II study of dovitinib in patients with metastatic and/or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib British Journal of Cancer 109, 2309 (29 October 2013). doi:10.1038/bjc.2013.594 Authors: Y-K Kang, C Yoo, B-Y Ryoo, J J Lee, E Tan, I Park, J H Park, Y J Choi, J Jo, J-S Ryu & M-H Ryu
Keywords:
gastrointestinal stromal tumourdovitinibimatinibsunitinib
Print ISSN:
0007-0920
Electronic ISSN:
1532-1827
Topics:
Medicine
Permalink